Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices
NHS hospitals in England used £112,957,563 of indicative cost of Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices in the 12 months to July 2026, about 0.4% of all hospital medicines spend. That is up 17.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Vedolizumab 108mg/0.68ml solution for injection pre-filled disposable devices most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Oxford University Hospitals Nhs Ft | £5,676,450 |
| University College London Foundation Tr | £3,785,325 |
| Sheffield Teaching Hospitals Nhs Trust | £3,652,075 |
| University Hospital Southampton Nhs Ft | £3,457,325 |
| London North West Healthcare Nhs Trust | £2,978,650 |
| Manchester University Nhs Ft | £2,918,688 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £2,756,225 |
| Gloucestershire Hpls Nhs Foundation Trst | £2,610,675 |
| Western Sussex Hospitals Nhs Found Trust | £2,422,075 |
| South Tees Hosp Nhs Foundation Trust | £2,246,800 |
The primary-care picture
Vedolizumab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Vedolizumab medicine page.